| Larry Richard Arnold, FNP-C | |
|
1031 Northridge Rd, Baldwyn, MS 38824-1173 | |
| (662) 365-9305 | |
| Not Available |
| Full Name | Larry Richard Arnold |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1031 Northridge Rd, Baldwyn, Mississippi |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548770514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 902362 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Tupelo, MS | Home health agency |
| Baptist Memorial Hospital Booneville | Booneville, MS | Hospital |
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nursemed Llc | 5294646782 | 9 |
News Archive
The Neurosurgery Research and Education Foundation (NREF), which reached an agreement with Codman & Shurtleff, Inc. (Codman) in December 2009 to provide funding to the NREF in support of the Foundation's new post-residency, clinical fellowship grant program, is pleased to announce that the following programs have been awarded fellowship funding for 2010-2011: Baylor College of Medicine (pediatric neurosurgery), Brigham & Women's Hospital (general neurosurgery),
Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology (ART), the 26th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday). Dr. Vivian Rittenberg, a Clinical Fellow in the Assisted Conception Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK, said that her research provided additional evidence to show that increased body mass index (BMI) was independently associated with a higher miscarriage rate after IVF or ICSI treatment.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
Researchers from the Harvard School of Public Health assessed the cost-effectiveness and clinical benefits of currently existing guidelines and new, proposed guidelines for screening women for chlamydia.
› Verified 4 days ago
| Entity Name | Nursemed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497820310 PECOS PAC ID: 5294646782 Enrollment ID: O20050105000262 |
News Archive
The Neurosurgery Research and Education Foundation (NREF), which reached an agreement with Codman & Shurtleff, Inc. (Codman) in December 2009 to provide funding to the NREF in support of the Foundation's new post-residency, clinical fellowship grant program, is pleased to announce that the following programs have been awarded fellowship funding for 2010-2011: Baylor College of Medicine (pediatric neurosurgery), Brigham & Women's Hospital (general neurosurgery),
Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology (ART), the 26th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday). Dr. Vivian Rittenberg, a Clinical Fellow in the Assisted Conception Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK, said that her research provided additional evidence to show that increased body mass index (BMI) was independently associated with a higher miscarriage rate after IVF or ICSI treatment.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
Researchers from the Harvard School of Public Health assessed the cost-effectiveness and clinical benefits of currently existing guidelines and new, proposed guidelines for screening women for chlamydia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larry Richard Arnold, FNP-C 1031 Northridge Rd, Baldwyn, MS 38824-1173 Ph: (662) 365-9305 | Larry Richard Arnold, FNP-C 1031 Northridge Rd, Baldwyn, MS 38824-1173 Ph: (662) 365-9305 |
News Archive
The Neurosurgery Research and Education Foundation (NREF), which reached an agreement with Codman & Shurtleff, Inc. (Codman) in December 2009 to provide funding to the NREF in support of the Foundation's new post-residency, clinical fellowship grant program, is pleased to announce that the following programs have been awarded fellowship funding for 2010-2011: Baylor College of Medicine (pediatric neurosurgery), Brigham & Women's Hospital (general neurosurgery),
Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology (ART), the 26th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday). Dr. Vivian Rittenberg, a Clinical Fellow in the Assisted Conception Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK, said that her research provided additional evidence to show that increased body mass index (BMI) was independently associated with a higher miscarriage rate after IVF or ICSI treatment.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
Researchers from the Harvard School of Public Health assessed the cost-effectiveness and clinical benefits of currently existing guidelines and new, proposed guidelines for screening women for chlamydia.
› Verified 4 days ago
Richard Comer, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 529 S Fourth St, Baldwyn, MS 38824 Phone: 662-620-1496 Fax: 662-365-2255 | |
Maggie Martin Smith, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 825 Road 1275, Baldwyn, MS 38824 Phone: 662-397-1106 | |
Miranda Lou Ford, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 121 S 2nd St, Baldwyn, MS 38824 Phone: 662-365-2725 | |
Mrs. Anita Joy Turner, FNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1031 Northridge Rd, Baldwyn, MS 38824 Phone: 662-365-9305 Fax: 662-365-9304 | |
Mrs. Heather Hancock, FNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1031 Northridge Rd, Baldwyn, MS 38824 Phone: 662-365-9305 Fax: 662-365-9304 | |
Louise Cristo, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 739 S Fourth St, Baldwyn, MS 38824 Phone: 662-401-1472 |